» Articles » PMID: 34036261

Recent Developments in Bio-scaffold Materials As Delivery Strategies for Therapeutics for Endometrium Regeneration

Overview
Journal Mater Today Bio
Date 2021 May 26
PMID 34036261
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Intrauterine adhesions (IUAs) refer to the repair disorder after endometrial injury and may lead to uterine infertility, recurrent miscarriage, abnormal menstrual bleeding, and other obstetric complications. It is a pressing public health issue among women of childbearing age. Presently, there are limited clinical treatments for IUA, and there is no sufficient evidence that these treatment modalities can effectively promote regeneration after severe endometrial injury or improve pregnancy outcome. The inhibitory pathological micro-environment is the main factor hindering the repair of endometrial damaged tissues. To address this, tissue engineering and regenerative medicine have been achieving promising developments. Particularly, biomaterials have been used to load stem cells or therapeutic factors or construct an delivery system as a treatment strategy for endometrial injury repair. This article comprehensively discusses the characteristics of various bio-scaffold materials and their application as stem cell or therapeutic factor delivery systems constructed for uterine tissue regeneration.

Citing Articles

Defining optimal electrospun membranes to enhance biological activities of human endometrial MSCs.

An J, Ma T, Wang Q, Zhang J, Santerre J, Wang W Front Bioeng Biotechnol. 2025; 13:1551791.

PMID: 40078795 PMC: 11896994. DOI: 10.3389/fbioe.2025.1551791.


The application of tissue engineering strategies for uterine regeneration.

Chen S, Yoo J, Wang M Mater Today Bio. 2025; 31:101594.

PMID: 40070871 PMC: 11894340. DOI: 10.1016/j.mtbio.2025.101594.


Advances in human umbilical cord mesenchymal stem cells-derived extracellular vesicles and biomaterial assemblies for endometrial injury treatment.

Zhang W, Wang H, Deng C World J Stem Cells. 2025; 17(1):97905.

PMID: 39866901 PMC: 11752459. DOI: 10.4252/wjsc.v17.i1.97905.


Mesenchymal stem cells: Guardians of women's health.

Gao G, Li L, Li C, Liu D, Wang Y, Li C Regen Ther. 2024; 26:1087-1098.

PMID: 39582803 PMC: 11585475. DOI: 10.1016/j.reth.2024.10.011.


Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine.

Motlagh Asghari K, Novinbahador T, Mehdizadeh A, Zolfaghari M, Yousefi M Heliyon. 2024; 10(20):e39584.

PMID: 39498089 PMC: 11532865. DOI: 10.1016/j.heliyon.2024.e39584.


References
1.
Li H, Ham T, Neill N, Farrag M, Mohrman A, Koenig A . A Hydrogel Bridge Incorporating Immobilized Growth Factors and Neural Stem/Progenitor Cells to Treat Spinal Cord Injury. Adv Healthc Mater. 2016; 5(7):802-12. DOI: 10.1002/adhm.201500810. View

2.
Holland I, Logan J, Shi J, McCormick C, Liu D, Shu W . 3D biofabrication for tubular tissue engineering. Biodes Manuf. 2018; 1(2):89-100. PMC: 6267270. DOI: 10.1007/s42242-018-0013-2. View

3.
Rasool A, Ata S, Islam A . Stimuli responsive biopolymer (chitosan) based blend hydrogels for wound healing application. Carbohydr Polym. 2018; 203:423-429. DOI: 10.1016/j.carbpol.2018.09.083. View

4.
Simoni M, Taylor H . Therapeutic strategies involving uterine stem cells in reproductive medicine. Curr Opin Obstet Gynecol. 2018; 30(3):209-216. DOI: 10.1097/GCO.0000000000000457. View

5.
Chi Y, He P, Lei L, Lan Y, Hu J, Meng Y . Transdermal estrogen gel and oral aspirin combination therapy improves fertility prognosis via the promotion of endometrial receptivity in moderate to severe intrauterine adhesion. Mol Med Rep. 2018; 17(5):6337-6344. PMC: 5928622. DOI: 10.3892/mmr.2018.8685. View